Bridgewater Bancshares director gets 969-share grant

Juran's report also identifies four trust-related holdings and describes his role differently for each trust.

Rhea-AI Filing Summary

Bridgewater Bancshares Inc director David B. Juran received a grant of 969 common shares on September 30, 2026, at a reported price of $0 per share. His reported direct holdings after the grant were 1,350,895 shares. The report also lists common shares held through four trusts: Juran is co-trustee of one, may possess investment power over shares in another, and is trustee of two others.

Insider Trade Summary

Grant/Award: 969 shares

Grant/Award 5 txns

Insider Juran David B.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	969	$0.00	$0.00
holding	Common Stock F1	--	--	--
holding	Common Stock F2	--	--	--
holding	Common Stock F3	--	--	--
holding	Common Stock F4	--	--	--

Holdings After Transaction: Common Stock — 1,350,895 shares (Direct); Common Stock — 201,580 shares (Indirect, By Trust)

Footnotes (4)

1. F1. Shares of common stock are held by Mr. Juran as co-trustee of a Residuary Trust dated June 18, 2002. Mr. Juran possesses shared voting and investment power with respect to the shares of common stock held under the trust.
2. F2. Mr. Juran is attorney-in-fact for a trustee who holds the shares of common stock as trustee of a Revocable Trust dated January 31, 2014. Mr. Juran is not a trustee of the trust, however Mr. Juran may possess investment power with respect to the shares of common stock held under the trust.
3. F3. Shares of common stock are held by Mr. Juran as trustee of Descendant's Separate Trust under a trust agreement dated September 17, 2018.
4. F4. Shares of common stock are held by Mr. Juran as trustee of Marital Trust 2 under a trust agreement dated September 17, 2018.

Key Figures

Grant: 969 shares Reported price per share: $0 per share Direct holdings after transaction: 1,350,895 shares

3 metrics

Grant 969 shares Common stock granted September 30, 2026

Reported price per share $0 per share Grant reported September 30, 2026

Direct holdings after transaction 1,350,895 shares Following the September 30, 2026 grant

Key Terms

co-trustee, attorney-in-fact, shared voting and investment power

3 terms

co-trustee regulatory

"as co-trustee of a Residuary Trust"

attorney-in-fact regulatory

"is attorney-in-fact for a trustee"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

shared voting and investment power regulatory

"possesses shared voting and investment power"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many BWB shares did director David B. Juran receive?

Bridgewater Bancshares director David B. Juran received a grant of 969 common shares on September 30, 2026. His reported direct holdings after the grant were 1,350,895 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/30/2026 - 05:34 PM Accepted by SEC EDGAR 09/30/2026 - 05:33 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Juran David B.

(Last) (First) (Middle)

C/O BRIDGEWATER BANCSHARES, INC.

4450 EXCELSIOR BLVD., SUITE 100

(Street)

ST. LOUIS PARK MINNESOTA 55416

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bridgewater Bancshares Inc [ BWB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/30/2026		A		969	A	$0	1,350,895	D
Common Stock								10,725	I	By Trust(1)
Common Stock								95,307	I	By Trust(2)
Common Stock								16,328	I	By Trust(3)
Common Stock								79,220	I	By Trust(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares of common stock are held by Mr. Juran as co-trustee of a Residuary Trust dated June 18, 2002. Mr. Juran possesses shared voting and investment power with respect to the shares of common stock held under the trust.

2. Mr. Juran is attorney-in-fact for a trustee who holds the shares of common stock as trustee of a Revocable Trust dated January 31, 2014. Mr. Juran is not a trustee of the trust, however Mr. Juran may possess investment power with respect to the shares of common stock held under the trust.

3. Shares of common stock are held by Mr. Juran as trustee of Descendant's Separate Trust under a trust agreement dated September 17, 2018.

4. Shares of common stock are held by Mr. Juran as trustee of Marital Trust 2 under a trust agreement dated September 17, 2018.

	/s/ Ben Klocke, Attorney-in-Fact	09/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)